Trilaciclib prior to chemotherapy reduces the usage of supportive care interventions for chemotherapy‐induced myelosuppression in patients with small cell lung cancer: Pooled analysis of three randomized phase 2 trials.

Autor:	Ferrarotto, Renata1 (AUTHOR) rferrarotto@mdanderson.org, Anderson, Ian2 (AUTHOR), Medgyasszay, Balazs3 (AUTHOR), García‐Campelo, Maria Rosario4 (AUTHOR), Edenfield, William5 (AUTHOR), Feinstein, Trevor M.6 (AUTHOR), Johnson, Jennifer M.7 (AUTHOR), Kalmadi, Sujith8 (AUTHOR), Lammers, Philip E.9 (AUTHOR), Sanchez‐Hernandez, Alfredo10 (AUTHOR), Pritchett, Yili11 (AUTHOR), Morris, Shannon R.11 (AUTHOR), Malik, Rajesh K.11 (AUTHOR), Csőszi, Tibor12 (AUTHOR)
Zdroj:	Cancer Medicine. Sep2021, Vol. 10 Issue 17, p5748-5756. 9p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu